Armata Pharmaceuticals (ARMP) Shareholder's Equity (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42.54% |
| Dec 31, 2025 | -128.69% |
| Sep 30, 2025 | -37.53% |
| Jun 30, 2025 | -29.23% |
| Mar 31, 2025 | -12.00% |
| Dec 31, 2024 | 5.80% |
| Sep 30, 2024 | -10.57% |
| Jun 30, 2024 | 18.42% |
| Mar 31, 2024 | -76.24% |
| Dec 31, 2023 | -158.88% |
| Sep 30, 2023 | -164.70% |
| Jun 30, 2023 | -14.72% |
| Mar 31, 2023 | -37.79% |
| Dec 31, 2022 | -20.84% |
| Sep 30, 2022 | -14.48% |
| Jun 30, 2022 | -13.40% |
| Mar 31, 2022 | 142.31% |
| Dec 31, 2021 | 6.91% |
| Sep 30, 2021 | -17.00% |
| Jun 30, 2021 | -15.86% |
| Mar 31, 2021 | 80.37% |
| Dec 31, 2020 | -23.40% |
| Sep 30, 2020 | -16.93% |
| Jun 30, 2020 | -11.48% |
| Mar 31, 2020 | 129.44% |
| Dec 31, 2019 | -19.52% |
| Sep 30, 2019 | -19.87% |
| Jun 30, 2019 | 472.14% |
| Mar 31, 2019 | -48.60% |
| Dec 31, 2018 | -12.53% |
| Sep 30, 2018 | -23.90% |
| Jun 30, 2018 | -21.40% |
| Mar 31, 2018 | -39.59% |
| Dec 31, 2017 | 149.49% |
| Sep 30, 2017 | -1.05% |
| Jun 30, 2017 | 48.33% |
| Mar 31, 2017 | -31.63% |
| Dec 31, 2016 | -46.66% |
| Sep 30, 2016 | -15.16% |
| Jun 30, 2016 | 141.47% |